Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 1,204.7 | 1,046.2 | 913.1 | 971.7 | 1,048.5 | 994.0 | 917.6 | 856.4 |
| Revenue growth | 15.2% | 14.6% | -6.0% | -7.3% | 5.5% | 8.3% | 7.1% | 5.6% |
| Cost of goods sold | 931.0 | 742.5 | 645.0 | 683.3 | 743.6 | 674.8 | 622.6 | 580.1 |
| Gross profit | 273.7 | 303.6 | 268.1 | 288.3 | 304.9 | 319.2 | 295.0 | 276.4 |
| Gross margin | 22.7% | 29.0% | 29.4% | 29.7% | 29.1% | 32.1% | 32.2% | 32.3% |
| Selling, general and administrative | 225.3 | 188.6 | 178.9 | 118.7 | 137.4 | 139.6 | 115.3 | 95.5 |
| Research and development | | | | 163.5 | 178.6 | 177.0 | 152.5 | 128.8 |
| EBIT | 48.3 | 115.0 | 91.2 | 74.4 | 76.1 | 97.1 | 106.1 | 121.3 |
| EBIT margin | 4.0% | 11.0% | 10.0% | 7.7% | 7.3% | 9.8% | 11.6% | 14.2% |
| Pre-tax income | 38.4 | 113.9 | 81.6 | 59.2 | 58.1 | 69.3 | 110.6 | 128.9 |
| Income taxes | 13.9 | 20.4 | 21.9 | 10.3 | 16.2 | 34.0 | 34.0 | 33.5 |
| Tax rate | 36.3% | 17.9% | 26.8% | 17.4% | 27.9% | 49.1% | 30.7% | 26.0% |
| Net income | 0.0 | 0.0 | 0.0 | 48.9 | 41.9 | 35.2 | 76.6 | 95.4 |
| Net margin | 0.0% | 0.0% | 0.0% | 5.0% | 4.0% | 3.5% | 8.3% | 11.1% |
| |
| Diluted EPS | $0.00 | $0.00 | $0.00 | $1.47 | $1.16 | $0.96 | $2.09 | $2.62 |
| Shares outstanding (diluted) | 33.5 | 33.5 | 33.0 | 33.3 | 36.2 | 36.8 | 36.6 | 36.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|